Comparison of Ex-PRESSTM Mini Glaucoma Shunt to Trabeculectomy in Subjects With Open Angle Glaucoma

Completed · Not applicable

Conditions studied: Glaucoma

In brief

A prospective randomized trial to compare the safety and efficacy of the Ex-PRESS to trabeculectomy in patients with open angle glaucoma who failed medical or are allergic to medical treatment and for which filtering surgery is indicated. Surgical success was defined as 5 mmHg ≤ intraocular pressure ≤ 18 mmHg, with or without medications, without further glaucoma surgery. Postoperative intraocular pressure, number of medications, complications and success rates were followed for 2 years.

Key facts

Study ID

NCT00444080

Run by

University of Virginia

People needed

120

Starts

2006-10-01

Expected to finish

2012-01-01

Last updated by the study team

2020-10-14

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult subject over the age of 18
• Subject diagnosed with open angle glaucoma (POAG, PXFG or PDSG) or ocular hypertension
• Subject is a candidate for filtering surgery with intraoperative anti-metabolites
• IOP > 18 mmHg on maximum tolerated medial therapy based on two measurements taken 1 hour apart at the same visit.
• Subject willing to attend all follow-up evaluations
• Subject willing to sign informed consent.

You may not qualify if…

• Subject diagnosed with: PACG, NTG, secondary glaucoma, neovascular glaucoma
• Subject has history of glaucoma surgery (filtering, glaucoma drainage device, cyclo destructive procedures)
• Subject has history of penetrating keratoplasty (PKP)
• Subject underwent large incision extra capsular cataract extraction
• Subject had cataract phacoemulsification within the last month
• Subject has a visually significant cataract that is planned for extraction at the time of filtering surgery or within 12 months thereafter
• Any ocular disease or history in the operated eye other than glaucoma and cataract, such as uveitis, ocular infection, severe dry eye, severe blepharitis , active proliferative retinopathy, ICE syndrome, epithelial or fibrous down growth, aphakia, and ocular pathology that may interfere with accurate IOP measurements
• Subject has vitreous present in the anterior chamber for which vitrectomy is anticipated
• IOP of ≤18mmHg
• Subject participates in any other concurrent ocular investigation.

Where it is running

• University of California — San Francisco, California, United States
• University of Florida — Gainesville, Florida, United States
• Washington University — St Louis, Missouri, United States
• Dean A. McGee Eye Institute — Oklahoma City, Oklahoma, United States
• Wills EYE Institute — Philadelphia, Pennsylvania, United States
• Allegheny Ophthalmic & Orbital Associates, P.C. — Pittsburgh, Pennsylvania, United States
• University of Tennessee — Memphis, Tennessee, United States
• Osler Eyecare — Mississauga, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.